Becton, Dickinson And Company · NYSE:BDX
Becton, Dickinson And — Conference Presentation (April 2020)
24 slides from Becton, Dickinson And's conference presentation, April 2020
Slide 1: These presentations were developed by the respective presenter(s)
These presentations were developed by the respective presenter(s), and the findings, interpretations, and conclusions contained or expressed with them do not necessarily reflect the views of BD. To the extent these presentations relate to specific products, such products should always be used in acc
Slide 2: Implementing a nurse led vascular access team
Implementing a nurse led vascular access team Núria Borràs-Maixenchs Hospital Clínic Barcelona
Slide 3: Disclosures
Disclosures In relation to this presentation, I declare BD covering traveling expenses and a presentation fee
Slide 4: Objective
Objective Present an overview of the history of the Infusion Therapy Team implementation at the Hospital Clinic of Barcelona Point out elements that helped to build the project Recent achievements and future team challenges
Slide 5: How did the service start and develop overtime?
How did the service start and develop overtime?
Slide 6: Learn from others' experiences
Learn from others' experiences • All catheter dressings looked-alike • Device selection • Taught patients and family members to perform catheter care: doing one-on- one teaching (empower patients)
Slide 7: Program replication
Program replication • Information sharing was difficult • No electronic databases to spread knowledge • There were no mechanisms other than magazine subscription
Slide 8: Trends in 2005
Trends in 2005 • Outpatient clinics development • Continuous intravenous chemotherapeutic infusion drugs were being incorporated into more treatment protocols • Shortening hospital stays • Home care programs
Slide 9: What played a great role?
What played a great role? • Infusion pump technology • Patient preferences • Pressing problem: to meet patient demands • Peripherally inserted central catheter (PICC) being placed by nurses
Slide 10: Case 1: TPF
Case 1: TPF TPF is the name of a Short daily infusions of 5-FU/ chemotherapy combination that Five-day continuous infusion of 5- includes FU • Docetaxel (Taxotere) Patients needed to have a central • Cisplatin line • Fluorouracil (5-FU) • Central line (CVC) • PICC line It is a treatment for head and
Slide 11: Case 1: TPF
Case 1: TPF Peripherally inserted central catheters of that time Ros M, Borràs N, Domingo JM “Identifying patients at high risk for venous thrombotic events related to 5-FU administered as a continuous infusion through peripherally inserted central venous catheter with ambulatory pump”. Presented EC
Slide 12: Case 1: TPF
Case 1: TPF Peripherally inserted central catheters of that time m! a n har d th go o ore d Ros M, Borràs N, Domingo Doménech JM “Identifyingo m patients at high risk for venous thrombothic events related to 5-FU e to administered as a continuous infusion k through peripherally inserted centralti m
Slide 13: 2011: Great leap forward
2011: Great leap forward New materials and products
Slide 14: Knowledge, skills and technology at patient's bedside
Knowledge, skills and technology at patient’s bedside • Designate only trained personnel for the • CLAB Zero campaign insertion • Bundles extended to all central lines • Line placement performed with ultrasound guidance • Catheter material improvement • Benefits of placing PICC devices using micro-p
Slide 15: IV Team- ICMHO
IV Team- ICMHO
Slide 16: Which benefits does the IV team offer to the hospital?
Which benefits does the IV team offer to the hospital? • The team currently operates with: 4RNs, 2 full time nurses, 2 part-time, infection control staff support and angioradiology assistance on demand • Responsible for: obtaining informed consent, outpatient and ward bed side PICC insertions, provi
Slide 17: Number of insertions performed by the IV team
Number of insertions performed by the IV team Institutes At 3 Months At 6 Months ICMHO PICC 167 PICC 332 ML 6 ML 25 ICMDiM PICC 46 PICC 106 ML 24 ML 56 ICEMEQ PICC 22 PICC 30 ML 10 ML 34 TOTAL AV 275 583
Slide 18: Specific IV team activities other than PICC placement
Specific IV team activities other than PICC placement 70 65 62 60 COL·LOCAR VP 50 PERMEAB/REFLUXE 36 40 33 NO COL·LOCAT* CONSULTES 30 RETIRAR AV 20 7 10 0
Slide 19: Catheter removal: indications
Catheter removal: indications *ICMHO: 6 cultius positius (dos del mateix malalt) ICMDiM: 1 cultiu positiu ICEMEQ: 0 cultiu positiu
Slide 20: Case 2
Case 2 On Friday evening, an allogenic Stem • What would be the benefits to Cell Transplant recipient presents to perform an emergency PICC insertion? the emergency room where she was diagnosed with herpes zoster related to the immunosuppressive therapy • Can you think of at least two reasons why?
Slide 21: Isolation precautions
Isolation precautions https://www.ons.org/practice-resources/pep
Slide 22: How do I see this service developing in the future?
How do I see this service developing in the future? • Educating healthcare personnel involved in care of patients in need of iv therapy • Improving patients’ safety • Clinical practice experts to adapt devices to patients/treatment requirements • Consultants I see them with Advanced Practice • Resea
Slide 23: ...recap ...
...recap ... Mandatory Ground preparation • Combine different fields of • Monitor, and evaluate care experts on patient safety To get started are critical to move ahead • The organization willing to • Policies and procedures in • Lear from mistakes support change and founding place • Specific traini
Slide 24: Thank you!
Thank you!
Becton, Dickinson And Company — Conference Presentation (April 2020) on 6ix